Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.0050 (0.27%) ($11.0050 - $11.0700) on Fri. Jul. 29, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.08% (three month average) | RSI | 51 | Latest Price | $11.0050(0.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -2.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(33%) VUG(31%) XLK(31%) VT(29%) BLOK(28%) | Factors Impacting BCRX price | BCRX will decline at least -2.04% in a week (0% probabilities). UUP(-15%) VIXM(-14%) SMH(-7%) EDOC(-4%) VXX(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.04% (StdDev 4.08%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $11.36 | 5 Day Moving Average | $10.95(0.5%) | 10 Day Moving Average | $11.24(-2.09%) | 20 Day Moving Average | $11.36(-3.12%) | To recent high | -9% | To recent low | 40.4% | Market Cap | $1.942b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |